Xijing Hospital clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 4 with minor changes only.

1. Notable

   Extended Sentinel Lymph Node Biopsy With Methylene Blue Single…Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

   Primary completion pushed from May 1, 2027 to May 1, 2028

   Also in this update: Trial status changed: Not Yet Recruiting → Active, Not Recruiting; Study completion pushed from May 15, 2028 to May 15, 2029

   Xijing Hospital·Not applicable· NCT07532096· Registry history of NCT07532096 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   Small-Molecule Compound XJH05 Ointment · Plaque Psoriasis

   Enrollment reduced: 5 → 3 participants

   Xijing Hospital·Not applicable· NCT07780929· Registry history of NCT07780929 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.